Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05815160
Title Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Debiopharm International SA
Age Groups: senior | adult
Covered Countries USA | ESP

No variant requirements are available.